Earnings Feed
Start Free
MYRIAD GENETICS INC·4

May 11, 4:07 PM ET

HOBDEN ADRIAN N 4

4 · MYRIAD GENETICS INC · Filed May 11, 2009

Insider Transaction Report

Form 4
Period: 2009-05-08
MYRIAD GENETICS INCMYGN
HOBDEN ADRIAN N
Pres. Myriad Pharmaceuticals
Transactions
  • Exercise/Conversion

    Common Stock

    2009-05-08$5.37/sh+12,502$67,136→ 190,486 total
  • Exercise/Conversion

    Incentive Stock Option (right to buy)

    2009-05-08−12,502→ 0 total
    Exercise: $5.37From: 2006-02-13Exp: 2013-02-13→ Common Stock (12,502 underlying)
  • Exercise/Conversion

    Incentive Stock Option (right to buy)

    2009-05-08−5,240→ 0 total
    Exercise: $6.27Exp: 2013-09-09→ Common Stock (5,240 underlying)
  • Exercise/Conversion

    Common Stock

    2009-05-08$6.27/sh+5,240$32,855→ 195,726 total
Footnotes (1)
  • [F1]The combined Incentive Stock Option and Non-Qualified Stock Option grants vest 25% annually beginning on the first anniversary date of the option grant, subject to statutory ISO limitations.

Documents

1 file
  • 4
    edgardoc.xmlPrimary

    PRIMARY DOCUMENT